However, current research indicates that cancer cells are able to manipulate chemokine networks to support tumor progression, with the main chemotactic axis utilized being that of C-C chemokine receptor type 5 (CCR5) and its ligand C-C chemokine ligand type 5 (CCL5).1 Here, CCL5 is linked to neoplasm.